1. Medtech Insight

Top Republican Senators Criticize Biden Administration For Lack Of COVID-19 Tests

The top GOPers on the Senate health committee want to know what the administration has done with more than $80bn allocated by Congress to ramp up production of COVID-19 tests.

Sens. Richard Burr, R-NC, (left) and Roy Blunt, R-MO, (right) wrote to HHS Sec. Xavier Becerra to criticize the administration's inability to provide more COVID-19 tests
Sens. Richard Burr, R-NC, (left) and Roy Blunt, R-MO, wrote to HHS Sec. Xavier Becerra to criticize the administration's inability to provide more COVID-19 tests • Source: Alamy

Two top Republican Senators on the US Senate Health, Energy, Labor and Pensions (HELP) Committee criticized the Biden administration’s COVID-19 testing strategy as a deluge of Omicron cases have overwhelmed the country and led to a shortage of tests.

HELP committee ranking member Sen. Richard Burr, R-NC, and Sen. Roy Blunt, R-MO, wrote to Xavier Becerra, secretary of the Department of Health and Human Services, on 3 January....

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Business

Salvia Bioelectronics Secures $60M In Series B To Advance Chronic Migraine Implant, Eyes US Trials

 
• By Marion Webb

Medtech Insight spoke with Hubert Martens, CEO of Netherlands-based neuromodulation company Salvia Bioelectronics, about the company’s innovative implant for treating chronic migraines, ongoing clinical trials and plans for US clinical trials and commercialization.

Industry Execs Talk Tariff Turbulence During MD&M East

 
• By Brian Bossetta

During MD&M East in Manhattan last week, a panel of experts discussed how the Trump administration’s trade policy is affecting manufacturing and offered some ideas on what manufacturers can do to help mitigate the chaos.

Bone Surgery Startup Surgify Medical Raises $7.9m

 
• By Natasha Barrow

Surgify Medical’s selective drill tip, Surgify Halo, is “an obvious choice for surgeons,” said Boris Hofmann, head of ZEISS Ventures and lead investor in the company’s series A funding round.

German Bionic Launches ‘Strongest Exoskeleton To Date’

 
• By Natasha Barrow

German Bionic’s new exoskeleton Exia helps healthcare practitioners, nurses, and other caregivers to lift and move patients by supporting muscle movement and reducing the risk of injury.

More from Medtech Insight

Industry Execs Talk Tariff Turbulence During MD&M East

 
• By Brian Bossetta

During MD&M East in Manhattan last week, a panel of experts discussed how the Trump administration’s trade policy is affecting manufacturing and offered some ideas on what manufacturers can do to help mitigate the chaos.

Bone Surgery Startup Surgify Medical Raises $7.9m

 
• By Natasha Barrow

Surgify Medical’s selective drill tip, Surgify Halo, is “an obvious choice for surgeons,” said Boris Hofmann, head of ZEISS Ventures and lead investor in the company’s series A funding round.

Commission’s Flora Giorgio Says Simplification And Safety Are Key In Evolving EU Regs

 
• By Amanda Maxwell

Predictability, proportionality, stability, harmonization and simplification offer the right way forward to address the challenging unintended effects of the EU medical device regulations, the European Commission’s head of devices tells the EU’s largest annual medtech conference.